Skip to main content
. 2021 Mar 22;11(3):807. doi: 10.3390/nano11030807

Figure 1.

Figure 1

Illustrations of the interactions involving SARS-CoV-2 RBD. (A) Interactions between the RBD portion of SARS-CoV-2 and the ACE2 receptor on the host cell can be impaired via neutralizing antibodies. (B) Interactions between HiBiT-RBD and LgBiT lead to the generation of bioluminescence signal after substrate digestion.